Skip to main content
. 2019 Feb 14;11(2):222. doi: 10.3390/cancers11020222

Figure 2.

Figure 2

Scanning Electron Microscope (SEM) images of NT 3–12 peptide-loaded 10% PEG-PLGA NPs (F7) after formulation.